Filing Details
- Accession Number:
- 0001209191-22-009745
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-15 16:05:31
- Reporting Period:
- 2021-10-15
- Accepted Time:
- 2022-02-15 16:05:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1626878 | Xbiotech Inc. | XBIT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1639078 | John Simard | 5217 Winnebago Lane Austin TX 78744 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-10-15 | 17,000 | $13.32 | 3,856,166 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-10-18 | 33,000 | $13.07 | 3,823,166 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.